New mammogram technique could reduce unnecessary breast biopsies
NCT ID NCT05046301
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special type of mammogram called contrast-enhanced mammography (CEM) can more accurately predict breast cancer in women with suspicious calcium spots in the breast. About 59 women with large areas of these spots will get both a standard mammogram and a CEM. The goal is to see if CEM reduces false alarms and helps avoid unnecessary biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simpler, cheaper method for marking breast tumors work as well as ultrasound?
- Could adding chemo help older breast cancer patients live longer? a major trial investigates.
- Saliva test could sharpen breast cancer risk prediction after abnormal biopsy
- Study probes whether tracking everyday chemical exposures could transform breast cancer prevention
- New PET tracer could spot cancers that standard scans overlook
- AI model aims to predict breast cancer therapy success